Skip to main content

Advertisement

Table 2 Mean (CI 95%) and analysis of variance (ANOVA) of baseline, Patient-Reported Outcomes

From: Effect of neuromuscular taping on musculoskeletal disorders secondary to the use of aromatase inhibitors in breast cancer survivors: a pragmatic randomised clinical trial

Self-Reported Outcomes T1: Baseline Evaluation
  Experimental (n = 20) Control (n = 20) ANOVA F(p)
POMS
 Tension/Anxiety 9.85 (7.39–12.30) 7.00 (3.87–10.12) 2.25 (0.14)
 Depression/Dejection 12.90 (7.51–18.28) 9.10 (4.44–13.75) 1.24 (0.27)
 Anger/Hostility 9.50 (5.98–13.01) 8.65 (4.67–12.62) 0.11 (0.73)
 Vigor/Activity 24.40 (20.23–28.56) 28.75 (25.34–32.15) 2.86 (0.09)
 Fatigue/Inertia 11.75 (9.51–13.98) 9.20 (7.26–11.13) 3.25 (0.07)
 Confusion/Bewilderment 8.60 (5.37–11.82) 6.55 (2.91–10.18) 0.77 (0.38)
 TMD 128.20 (113.47–142.93) 111.75 (96.55–126.95) 2.64 (0.11)
EORTC QLQ-C30
 Global health status/QoL 53.74 (41.84–65.64) 57.08 (46.77–67.38) 0.19 (0.66)
Functional scales
 Physical functioning 67.61 (56.17–79.04) 76.91 (67.47–86.35) 1.72 (0.19)
 Role functioning 75.83 (60.75–90.90) 79.16 (64.87–93.45) 0.11 (0.73)
 Emotional functioning 72.56 (59.55–85,57) 79.68 (69.72–89.63) 0.82 (0.36)
 Cognitive functioning 81.66 (69.29–94.03) 79.99 (67.96–92.02) 0.04 (0.84)
 Social functioning 79.99 (64.68–95.30) 90.83 (83.04–98.62) 1.74 (0.19)
Symptoms scales
 Fatigue 51.07 (40.48–61.65) 40.53 (30.50–50.56) 2.28 (0.13)
 Nausea and vomiting 0.87 (0.96–2.71) 1.66 (0.73–4.06) 0.29 (0.59)
 Pain 50.83 (38.31–63.35) 38.33 (27.27–49.39) 2.45 (0.12)
 Dyspnoea 6.66 (−4.18–17.52) 8.33 (−2.84–19.50) 0.05 (0.82)
 Insomnia 53.33 (37.00–69.65) 44.99 (25.87–64.12) 0.48 (0.49)
 Appetite loss 14.99 (2.12–27.87) 14.99 (3.15–26.84) 0.00 (1.00)
 Constipation 4.99 (−2.63–12.63) 8.33 (−1.63–18.29) 0.30 (0.58)
 Diarrhoea 11.66 (0.04–23.28) 6.66 (−2.93–16.28) 0.48 (0.49)
 Financial difficulties 8.33 (−3.93–20.60) 14.99 (2.12–27.87) 0.61 (0.43)
 VAS 7.40 (6.82–7.98) 6.65 (5.98–7.32) 3.17 (0.08)
 SFI 57.40 (49.59–65.20) 56.90 (47.66–66.13) 0.007 (0.93)
 ULFI 61.80 (53.93–69.66) 69.60 (62.07–77.12) 2.25 (0.14)
 BAI 0.59 (0.47–0.71) 0.42 (0.28–0.55) 4.07 (0.05)
 MBS 0.40 (0.23–0.56) 0.33 (0.21–0.44) 0.53 (0.46)
 BADIX 0.53 (0.41–0.65) 0.40 (0.28–0.51) 2.93 (0.09)
  1. Abbreviations: POMS Profile of Mood States, TMD Total Emotional Distortion, EORTC QLQ-C30 European Organization for Research and Treatment of Cancer (EORT) Quality of Life Questionnaire QLQ-C30, QoL Quality of Life, VAS Visual Analogue Scale, SFI Spine Functional Index, ULFI Upper Limb Functional Index, BAI Backache Index, MBS Morning Stiffness Score, BADIX Backache Disability Index